BCHlogomotto primary 72dpi

Kahn HeadshotPrincipal Investigator: Dr. Stacy Kahn

Disease: Clostridium difficile infection

Research Description: Fecal microbiota transplantation (FMT) is the repurposing of human stool to deliver healthy bacteria to the gastrointestinal tract of individuals with disease, most notably Clostridium difficile infection (CDI). CDI is an increasing health care burden and is the leading cause of hospital-associated gastrointestinal illness. FMT has become a cost effective and life-saving treatment for patients with recurrent and refractory Clostridium difficile infection who have not responded to conventional antibiotic treatment. Dr. Kahn will create a pediatric patient registry to study FMT in children. This patient registry will be used to study the natural history of CDI and the safety and efficacy of treatment with repurposed stool through FMT. Dr. Kahn will also pursue a proof concept clinical trial testing swallowed human microbiota capsules to treat CDI infections in children.

CWR funding role: Primary funder

CWR funding start date: June 2017

Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*

*required

If the link above doesn't work, please email susan@cureswithinreach.org with your Full Name and Email Address to sign up!

 

Thanks for your patience while the donation form loads!

Cures Within Reach

info@cureswithinreach.org

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes.  CWR is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.

 

Wednesday the 24th. Copyright 2018 Cures Within Reach.